Liposomes have been the centre of attention in research due to their potential to act as drug 20 delivery systems. Although its versatility and manufacturing processes are still not scalable and 21 reproducible. In this study, the microfluidic method for liposomes preparation is presented.
Introduction

36
Liposomes are lipid structures that can be self-assembled naturally or prepared with natural or vivo fate of the liposome by affecting its loading and releasing properties [Heurtault, 2003] . 44 Liposome production aims to achieve predictable and reproducible particle size distributions 45 [Kreuter, 1994] . Commonly used methods for liposome formulation include hydration of lipids 3000-1500 cm -1 over 128 scans at a resolution of 4 cm -1 and an interval of 1 cm -1 . All FT-IR 127 spectra were recorder on BRUKER tensor II FT-IR Spectrometer and the background was 128 subtracted from each spectrum. The 7 ml of PBS were removed and replace with fresh PBS and drug release profiles was 152 analysed by extraction of 500 µL aliquots of the immersion medium at intervals of 30 min, 1, Although no significant differences were detected in mean size distribution of particles 192 manufactured from 1 to 6 and 6 to 20 ml min -1 . Particles fabricated at 20 ml min -1 are smaller 193 than the ones obtained at 1 ml min -1 . Furthermore, particles formed with 1:1 lipid/cholesterol 194 ratios were smaller. In Fig. 4 the increase of TFR (6 and 20 ml ml -1 ) and with the increase of FRR (5:1). The graphs obtained 228 from the stability studies of the most stable formulations can be found in Fig. 4 values of encapsulation efficiency than Q, even though they were produced by a different 235 method.
236
Hydrophilic and hydrophobic drugs will be loaded into the liposomes on different sites. 
FT-IR
285
IR spectroscopy is a complex method, which is especially useful since the resulting spectrum 286 acts as a fingerprint for compounds. This analysis was performed on the four formulations that 287 were the most stable (DMPC/CH 1:1 TFR20 ml min -1 FR5:1, DMPC/CH 2:1 TFR6 ml min -1 288 5:1, DSPC/CH 1:1 TFR6 ml min -1 3:1, and DSPC/CH 2:1 TFR20 ml min -1 5:1). Medium formulations showed an initial burst of drug release. AT showed similar release profiles for the 308 different formulations. In our previous paper, each time liposomes were formulated by 309 hydration method, AT release resulted in faster release than Q.
310
In this study, there is not a distinct behaviour between AT and Q. AT presents a faster release 311 profile for DMPC formulations. On the contrary, Q shows a faster release for DSPC 312 formulations, especially for 1:1 DSPC that was prepared at TFR of 20 ml min -1 and FRR 5:1.
313
This may be related to the fact that DSPC has an increased lipid chain length, and there seems 314 to be a tendency for an increase of loading and encapsulation efficiency with increasing lipid Formulations which contained 2:1 lipid/cholesterol contents, presented faster release profiles 323 with higher maximum releases, when compared with formulations with 1:1 lipid/cholesterol 324 ratio. According to previous studies with hydrophobic drugs, higher retention rates are seen 325 with the increase of CH content in the formulation. As CH is present in increasing contents, it 326 stabilizes liposomes but it obstructs the leakage of hydrophobic drugs [Ali et al., 2010] . Despite 327 this, 1:1 DSPC formulation encapsulated with Q, showed the fastest release.
328
From these results, we can see that microfluidic manufacturing may alter the way drugs are 329 loaded within the liposomes formed, ultimately causing changes in release profile of a specific 330 drug. This method allows different outcome possibilities accordingly to the lipid and drug in 331 question. When comparing these results with our previous study, we can see that altering 332 microfluidic parameters influences the drugs interaction with the liposomes, making it possible 333 to achieve faster release profiles for Q.
334
The developed fitting model, based on Eq. 1, can be seen in Fig. 8 and values for the constants 335 of , and can be found in Table 3 . From Fig. 8 , a good correlation between drug release 336 profiles obtained in this study and the predicted values can be observed. These results validate 337 the obtained mathematical model. 
Conclusions
339
In this study, we showed the applicability of microfluidic manufacturing method as a simpler Description:
464 Table 1 shows results of Encapsulation Efficiency (%EE) for Atenolol and Quinine using the 465 best formulations obtained from previous experiences. Table 2 shows liposome sizes for AFM images.
